US Amlodipine Besylate prices during the entire month of October 2025 witnesses a rise steadily despite growing turmoil in the pharma industry. The revival is catalyzed by supply side reduction, raw material and production cost increases, and rebound downstream demand for this critical anti-hypertensive API. India and China lead producers all confirm high operational costs owing to tightening environmental regulations, increased energy and shipping, and volatility in intermediate prices. While improved demand for Amlodipine Besylate by formulation manufacturers and downstream sectors across the importing nations, have contributed to higher market tightness. Furthermore, currency devaluation in certain import-dependent economies increased landed costs for Amlodipine Besylate, further supporting higher prices. Price analysts anticipate prices continuing higher to November 2025, and thereafter, with minimal likelihood of near-term revision except when supply increases or input prices fall. Specialists advise drugmakers to implement strategic buying Amlodipine Besylate strategies, lock in long-term commitments, and watch closely for marketplace factors to reduce the impact of continued price volatility and supply shortages.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
